# Virax Biolabs Group (VRAX) — News

VRAX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vrax/news

## Recent headlines

- [Monkeypox stocks rose in intraday trading, with VRAX up 6.67%, GILD gaining 2.75% and VTRS rising 2.12%.](https://www.ainvest.com/news/monkeypox-stocks-rose-intraday-trading-vrax-6-67-gild-gaining-2-75-vtrs-rising-2-12-2610-84) — AInvest Wire, Oct 15, 2026
- [Monkeypox stocks rose in after-hours trading, with VRAX up 0% and SIGA gaining 0%.](https://www.ainvest.com/news/monkeypox-stocks-rose-hours-trading-vrax-0-siga-gaining-0-2610-70) — AInvest Wire, Oct 14, 2026
  Monkeypox-related stocks showed mixed performance in after-hours trading on October 14, 2026. Virax Biolabs Group Limited (VRAX) remained unchanged, while SIGA Technologies, Inc. (NASDAQ:SIGA) also posted a 0% gain. The lack of movement in these stocks contrasts with the ongoing global health…
- [Monkeypox stocks fell in intraday trading, with INO down 9.0%, TNXP falling 3.5% and VRAX sliding 2.7%.](https://www.ainvest.com/news/monkeypox-stocks-fell-intraday-trading-ino-9-0-tnxp-falling-3-5-vrax-sliding-2-7-2610-52) — AInvest Wire, Oct 13, 2026
- [Virax Biolabs Group Limited announces exercise of preferred investment options for $3.3 million gross proceeds](https://www.ainvest.com/news/virax-biolabs-group-limited-announces-exercise-preferred-investment-options-3-3-million-gross-proceeds-2607) — AInvest Wire, Jul 9, 2026
  Virax Biolabs Group Limited (Nasdaq: VRAX) announced on July 9, 2026, that it has received gross proceeds of $3.3 million from the exercise of preferred investment options issued in a prior private placement. The exercise of these options is part of the company’s ongoing capital-raising efforts and…
- [Virax Biologics signs multi-country commercial supply agreement with Fosun Diagnostics](https://www.ainvest.com/news/virax-biologics-signs-multi-country-commercial-supply-agreement-fosun-diagnostics-2607) — AInvest Wire, Jul 9, 2026
  Virax Biolabs Group Limited (NASDAQ: VRAX) has entered into a multi-country commercial supply agreement with Fosun Diagnostics, expanding its global reach for the distribution of its diagnostic products. Under the terms of the agreement, Fosun Diagnostics will supply Virax’s ImmuneSelect and…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).